Nephros (NEPH) Shares Outstanding (2010 - 2026)
Nephros (NEPH) posted quarterly Shares Outstanding (Entity) of $10.8 million for Q1 2026, up 2.29% year-over-year from $10.6 million in Q1 2025, and up 1.87% quarter-over-quarter from $10.6 million in Q4 2025.
Nephros (NEPH) Shares Outstanding (2010 - 2026) Analysis & Trends
Nephros' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $10.8 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 2.29% year-over-year to $10.8 million; the TTM figure through Mar 2026 stood at $10.8 million (up 2.29% YoY), while the FY2025 annual figure was $10.6 million, up 0.94% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $10.8 million, up from $10.6 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $10.8 million in Q1 2026, with the low at $10.3 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $10.5 million (2024), against an average of $10.5 million.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) gained 3.75% in 2022, then retreated 0.06% in 2023.
- Nephros' Shares Outstanding (Entity) stood at $10.3 million in 2022, then rose by 1.98% to $10.5 million in 2023, then increased by 0.41% to $10.5 million in 2024, then gained by 0.94% to $10.6 million in 2025, then increased by 1.87% to $10.8 million in 2026.
- Business Quant data shows NEPH's Shares Outstanding (Entity) at $10.8 million in Q1 2026, $10.6 million in Q4 2025, and $10.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 354.10 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 274.79 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 486.70 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 145.52 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 857.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 70.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 172.70 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 195.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 517.00 Mn |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | 10.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.86 Mn |
| Mar 31, 2026 | 10.65 Mn |
| Dec 31, 2025 | 10.61 Mn |
| Sep 30, 2025 | 10.61 Mn |
| Jun 30, 2025 | 10.60 Mn |
| Mar 31, 2025 | 10.60 Mn |
| Dec 31, 2024 | 10.53 Mn |
| Sep 30, 2024 | 10.54 Mn |
| Jun 30, 2024 | 10.51 Mn |
| Mar 31, 2024 | 10.50 Mn |
| Dec 31, 2023 | 10.39 Mn |
| Sep 30, 2023 | 10.46 Mn |
| Jun 30, 2023 | 10.30 Mn |
| Mar 31, 2023 | 10.30 Mn |
| Dec 31, 2022 | 10.30 Mn |
| Sep 30, 2022 | 10.30 Mn |
| Jun 30, 2022 | 10.30 Mn |
| Mar 31, 2022 | 10.21 Mn |
| Dec 31, 2021 | 10.02 Mn |
| Sep 30, 2021 | 10.04 Mn |